This Royal Society conference will bring together scientists, medical practitioners and funding bodies to raise awareness and interest for new anti-microbial advances.

Anti-microbial resistance continues to grow as a worldwide health challenge. Pathogens are continually evolving to combat drugs given to treat potentially life-threatening diseases, rendering treatments ineffective and threatening the many advances in fighting microbes over recent decades.

As therapeutics in current use become less effective, new approaches are required. This event aims to raise awareness and interest for new anti-microbial advances, the challenges faced in market delivery, and their appropriate use in healthcare systems.

About the conference series:
The conference is part of the Royal Society’s Transforming our future conferences in the life sciences, supported by AstraZeneca. These meetings are unique, high-level events that address the scientific and technical challenges of the next decade. Each conference features cutting edge science from industry and academia and brings together leading experts from the scientific community, including regulatory, charity and funding bodies. This conference also forms part of the Academy of Medical Sciences’ FORUM programme.

CARB-X participants include Erin Duffy, Chief of R&D, who will participate in the session ‘Challenges of prescribing, diagnostics and antibiotic education, investment and building a business model for new antibiotics’ between 3.30pm – 4.30pm EST.

Click here to learn more.
Click here to register.